Summary
E.I. du Pont de Nemours and Company (DuPont) reported strong performance in the second quarter and first half of 2011, driven by significant net sales growth and increased net income attributable to DuPont. Net sales rose 19% year-over-year for both the quarter and the year-to-date period, primarily due to higher selling prices and increased sales volume across various regions, with particular strength in developing markets. The company's strategic acquisition of Danisco A/S, a global enzyme and specialty food ingredients company, was a major driver of this growth, contributing to expanded business segments in Industrial Biosciences and Nutrition & Health. Despite increased costs related to the Danisco acquisition, such as transaction fees and inventory step-up charges, DuPont demonstrated robust profitability with net income attributable to DuPont increasing by 5% for the quarter and 16% year-to-date. The company also provided an updated full-year 2011 earnings outlook, reflecting the positive impact of the Danisco acquisition and strong quarterly results. DuPont continues to focus on innovation, growth in key areas like agriculture and high-value materials, and operational productivity to maintain a strong financial position.
Financial Highlights
50 data points| Revenue | $9.16B |
| R&D Expenses | $462.00M |
| SG&A Expenses | $1.14B |
| Operating Expenses | $8.90B |
| Operating Income | $1.94B |
| Interest Expense | $115.00M |
| Net Income | $1.23B |
| EPS (Basic) | $1.31 |
| EPS (Diluted) | $1.29 |
| Shares Outstanding (Basic) | 930.80M |
| Shares Outstanding (Diluted) | 943.99M |
Key Highlights
- 1Net sales increased by 19% to $10.3 billion for the second quarter of 2011 compared to the prior year, driven by higher selling prices and increased volume.
- 2Net income attributable to DuPont grew 5% to $1.218 billion for the second quarter of 2011, and 16% to $2.649 billion year-to-date.
- 3The acquisition of Danisco A/S was completed in May 2011 for approximately $6.4 billion, significantly expanding DuPont's presence in industrial biotechnology and food ingredients.
- 4The company saw strong growth in developing markets, with sales up 29% year-to-date.
- 5Earnings per diluted share were $1.29 for the second quarter of 2011, up from $1.26 in the prior year.
- 6Cash used for operating activities was $644 million for the first six months of 2011, compared to $424 million used in the same period of 2010, reflecting increased working capital needs primarily due to the Danisco acquisition.
- 7DuPont updated its full-year 2011 earnings outlook to a range of $3.53-$3.79 per share.